One-fifth of the Canadian population has now received at least one dose of a vaccine to protect against the deadly COVID-19 disease.
The country hit the milestone on Tuesday, having now administered a first dose to 7,689,563 people in Canada, or just over 20 per cent of the population, according to COVID Tracker Canada.
Canada has a population of about 37.7 million people. Approximately 31.5 million people are over the age of 16 and eligible to receive a COVID-19 vaccine.
To date, 2.1 per cent of the population is fully vaccinated, meaning they have received the required two doses of vaccine.
![Click to play video: 'Feds facing criticism over Canada’s bleak COVID-19 vaccination rate'](https://i0.wp.com/media.globalnews.ca/videostatic/news/j8vu05rb2g-htdtjnjojx/0406_abigail.jpg?w=1040&quality=70&strip=all)
Health Canada first approved a vaccine for use in December of 2020, green-lighting a shot from Pfizer-BioNTech. Days after it was approved, the first doses arrived in Canada and were administered.
In the months since December, Health Canada approved three more vaccines from Moderna, AstraZeneca and Johnson & Johnson.
![Receive the latest medical news and health information delivered to you every Sunday.](https://globalnews.ca/wp-content/themes/shaw-globalnews/images/skyline/healthiq.jpg)
Get weekly health news
However, lacking the capability to manufacture the shots at home, Canada has relied entirely on vaccines from overseas.
Due to this, the country has been at the mercy of a competitive global market, and has experienced repeated delays from manufacturers in its attempt to bring shots into Canada.
It has taken four months to deliver a first dose to 20 per cent of the Canadian public.
So far, the country has signed deals with a number of manufacturers to secure more than 400 million COVID-19 doses.
In comparison, the United States has administered nearly 190,000,000 COVID-19 shots, and fully vaccinated 22.3 per cent of its population.
U.S. President Joe Biden has said that 90 per cent of the American population would be eligible to get a COVID-19 vaccine by April 19.
Meanwhile, the United Kingdom has doled out 39,846,781 COVID-19 shots, and has fully vaccinated 14.5 per cent of its population.
In March, the U.K. announced half of the country’s total population had received their first dose.
![Click to play video: 'U.K. study examines safety of mixing COVID-19 vaccines'](https://i0.wp.com/media.globalnews.ca/videostatic/news/2lymfj8g8i-kx1ffn4wvr/0328_crystal.jpg?w=1040&quality=70&strip=all)
In an effort to vaccinate more people faster, Canada’s National Advisory Committee on Immunization (NACI) has recommended provinces and territories delay delivering second doses up to four months.
All of the approved vaccines, except for the one from Johnson & Johnson, require two doses delivered some weeks apart.
The federal government has announced it has signed a deal with Novavax to produce vaccines at home in a facility in Montreal currently under construction. However, doses are not expected to be manufactured within the country until at least the fall.
September deadline?
The federal government has maintained that all Canadians who want a COVID-19 vaccine will have access to one by the end of September.
However, experts say in order to hit that target, Canada will need to significantly ramp up its deliveries.
In a previous interview, Colin Furness, an infection control epidemiologist at the University of Toronto, told Global News in order to hit that target, we would have to deliver 400,000 doses per day.
Something he said is “achievable.”
“At some point, we’ll start involving primary care physicians and pharmacies on a scale that will allow for a lot faster inoculation, which is what should have been done in the first place,” he said.
–With a file from Global News’ Emerald Bensadoun
Comments